Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
32M
-
Shares change
-
-2.4M
-
Total reported value, excl. options
-
$119M
-
Value change
-
-$11.1M
-
Put/Call ratio
-
2.22
-
Number of buys
-
65
-
Number of sells
-
-55
-
Price
-
$3.72
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q2 2022
154 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q2 2022.
ImmunityBio, Inc. - COM (IBRX) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (7.52M shares), BlackRock Inc. (5.91M shares), STATE STREET CORP (1.87M shares), GEODE CAPITAL MANAGEMENT, LLC (1.57M shares), MILLENNIUM MANAGEMENT LLC (1.18M shares), JPMORGAN CHASE & CO (1.16M shares), CITADEL ADVISORS LLC (778K shares), NORTHERN TRUST CORP (755K shares), CREDIT SUISSE AG/ (688K shares), and ALLEN HOLDING INC /NY (688K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.